In the quiet aftermath of a university student's death in Chennai, a bacterial infection long mistaken for other fevers has stepped into the light. Scrub typhus — spread not by mosquitoes but by the bite of tiny larval mites — has been circulating through South Asia for years, underdiagnosed and underestimated, while claiming lives that timely treatment could have saved. A 2025 study now confirms it as the leading infectious cause of encephalitis in southern India, placing an old, overlooked disease at the center of a new and urgent public health reckoning.
Scrub Typhus: A Growing Health Crisis in South Asia Demands Urgent Action
scrub typhus is now the leading infectious cause of encephalitis in southern India
So this student died from something spread by mites, not mosquitoes. How many people in India actually have this infection right now?
That's the thing—nobody really knows. The 2021 review found that in community studies, about 34 percent of people showed evidence of past infection. But those are just the people who were tested. Most cases probably go undiagnosed.
Right, and that 34 percent figure is from seroprevalence studies, which means people who had it at some point. That's different from how many people have it right now. We don't have current prevalence numbers.
Why is it so hard to diagnose?
The symptoms look like dengue, leptospirosis, malaria—fever, headache, body aches. Doctors see those and think of the more common diseases first. By the time someone thinks to test for scrub typhus, the patient might already be very sick.
And there's no rapid test. You need a blood test, IgM ELISA or PCR. That takes time. In a rural area, you might not have access to that at all.
But once you know what it is, can you treat it?
Yes. Doxycycline or azithromycin work well if you start them early. A 2023 trial showed that using both together works even better than either one alone.
That trial was done in seven centres in India, so it's solid evidence for the Indian context. But the key word is "early." If you wait too long, the damage is done—respiratory failure, kidney failure, meningitis.
Is there a vaccine?
No. There's no vaccine yet. So it's all about prevention through protective clothing, insect repellent, and keeping your environment clean.
Which is easier said than done if you're living in an agricultural area or a rural community where chiggers are everywhere. Prevention advice assumes a level of access and control that not everyone has.
Il Polso
- An Anna University student died on September 18, 2026, from scrub typhus at a Chennai hospital — a death that has forced an institution, and a region, to confront a disease hiding in plain sight.
- Because its symptoms mirror dengue and other fevers, scrub typhus is routinely misdiagnosed, and patients often reach critical stages — respiratory failure, kidney collapse, coma — before the correct answer is found.
- A 2025 multi-centre study of nearly 600 children across three southern states found scrub typhus is now the single most common infectious cause of acute encephalitis, signaling a disease burden far larger than official records reflect.
- Effective antibiotics exist — doxycycline and azithromycin, and a 2023 trial found their combination works faster and with fewer complications — but they can only save lives if diagnosis arrives in time.
- With no vaccine available and prevention limited to repellents and protective clothing, public health systems face mounting pressure to build the surveillance infrastructure that five years of warnings have yet to produce.
In the quiet aftermath of a university student's death in Chennai, a bacterial infection long mistaken for other fevers has stepped into the light. Scrub typhus — spread not by mosquitoes but by the bite of tiny larval mites — has been circulating through South Asia for years, underdiagnosed and underestimated, while claiming lives that timely treatment could have saved. A 2025 study now confirms it as the leading infectious cause of encephalitis in southern India, placing an old, overlooked disease at the center of a new and urgent public health reckoning.
On September 18, 2026, a student at Anna University died of scrub typhus at Government Kilpauk Medical College Hospital in Chennai. The death was not an anomaly — it was a visible rupture in a pattern that has been building quietly for years. University authorities responded by launching screenings for scrub typhus, dengue, and leptospirosis alike, an acknowledgment that the threat is systemic, not singular.
Scrub typhus is caused by the bacterium Orientia tsutsugamushi, transmitted through the bite of infected larval mites known as chiggers — not mosquitoes, a distinction that has long contributed to misdiagnosis. The disease is endemic across South and Southeast Asia, yet a 2021 systematic review described it as grossly underrecognized in India, finding it responsible for over a quarter of acute undifferentiated fever cases studied, with more than a third of community members showing evidence of past infection.
The scale of the problem has grown clearer with time. A 2025 multi-centre study of 587 children across Karnataka, Andhra Pradesh, and Tamil Nadu found scrub typhus to be the most common infectious cause of acute encephalitis syndrome in southern India — a finding that suggests countless prior cases were attributed to other diseases entirely.
The illness begins within ten days of infection: fever, headache, body aches, and often a dark eschar at the bite site. Without treatment, it can escalate to respiratory distress, meningitis, kidney failure, and death. Diagnosis is complicated by symptom overlap with other diseases, and blood tests confirming the infection are only ordered when a clinician thinks to ask. Once identified, the disease responds well to antibiotics — doxycycline or azithromycin — and a 2023 Indian trial found that combining both produced faster recovery and fewer organ complications than either drug alone.
There is no vaccine. Chiggers thrive in grass, vegetation, and agricultural soil, and prevention depends on covered footwear, repellent, and clearing mite habitats. These are modest defenses. The 2021 review that first sounded the alarm called for urgent surveillance and control measures. Five years on, with a student dead and a new study confirming scrub typhus as a leading neurological threat, that call has grown only more pressing — and the response remains the open question.
An Anna University student died of scrub typhus on September 18, 2026, at Government Kilpauk Medical College Hospital in Chennai. The death has forced the university to confront a bacterial infection that has been quietly circulating through South Asia for years, largely unrecognized and often misdiagnosed. University authorities have now begun screening students not only for scrub typhus but also for dengue and leptospirosis—a sign that the institution understands this is not an isolated case but part of a larger pattern.
Scrub typhus is caused by a bacterium called Orientia tsutsugamushi, transmitted through the bite of infected larval mites, commonly called chiggers. It is not a mosquito-borne disease, which is why many people mistake it for dengue or other vector-borne illnesses. The infection is endemic across South and Southeast Asia, yet a 2021 systematic review described it as "a grossly under-recognised public health problem in India." The same review found that scrub typhus accounted for 25.3 percent of acute undifferentiated febrile illness cases studied, and that 34.2 percent of people in communities showed evidence of past infection. The disease causes severe illness and death, but its true burden remains underappreciated by public health systems.
Recent research has sharpened the picture of how serious the problem has become. A 2025 multi-centre study examined 587 children across Karnataka, Andhra Pradesh, and Tamil Nadu who had been diagnosed with acute encephalitis syndrome—a condition that causes brain inflammation and can be fatal. The findings were stark: scrub typhus emerged as the single most common infectious cause of encephalitis in southern India. This represents a significant shift in the disease landscape and suggests that many cases may have been attributed to other causes in the past.
Symptoms typically appear within ten days of infection. They include fever and chills, headache, body aches, and muscle pain. A distinctive dark, scab-like mark called an eschar often appears at the site of the chigger bite. Some patients experience mental changes ranging from confusion to coma, enlarged lymph nodes, and a rash. If the infection goes untreated, it can progress to acute respiratory distress syndrome, shock, meningitis, and kidney failure—any of which can be fatal. In India, mortality rates remain high, primarily because diagnosis comes too late and treatment is delayed.
Diagnosis itself is a challenge. The symptoms of scrub typhus overlap with so many other diseases that doctors often miss it or identify it only after the patient has already become severely ill. A blood test using IgM ELISA or PCR can confirm the diagnosis, but only if someone thinks to order it. Once identified, the infection responds well to antibiotics. Doxycycline or azithromycin are the standard treatments. A 2023 trial conducted across seven centres in India found that combining both antibiotics produced faster recovery and fewer complications than using either drug alone. Patients on combination therapy experienced lower rates of respiratory, kidney, liver, and nervous system complications compared to those on monotherapy.
There is no vaccine for scrub typhus, and the infection cannot spread from person to person. Chiggers thrive in grassy areas, thick vegetation, agricultural fields, plant litter, and bare soil across rural Asia. They typically feed on small mammals like rats and shrews. Prevention relies on personal protective measures: wearing covered footwear, using insect repellent, and keeping one's surroundings clean and well-maintained to reduce mite habitats. These are modest tools against a disease that has already claimed lives and will claim more without intervention.
The 2021 review that documented scrub typhus as an underrecognized crisis concluded with a call to action: "Early diagnosis and prompt treatment can significantly reduce complications and mortality. Establishing good surveillance and instituting appropriate control measures are urgently needed." Five years later, with a university student dead and a new study confirming that scrub typhus is now the leading infectious cause of encephalitis in southern India, that urgency has only grown. The question is whether public health systems will respond with the speed and resources the moment demands.
Citazioni salienti
Scrub typhus is a grossly under-recognised public health problem in India— 2021 systematic review
Early diagnosis and prompt treatment can significantly reduce complications and mortality. Establishing good surveillance and instituting appropriate control measures are urgently needed— 2021 systematic review